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Background: Accurate, timely and automated identification of patients at high risk for severe clinical deterioration
using readily available clinical information in the electronic medical record (EMR) could inform health systems to
target scarce resources and save lives.
Methods: We identified 7,466 patients admitted to a large, public, urban academic hospital between May 2009 and
March 2010. An automated clinical prediction model for out of intensive care unit (ICU) cardiopulmonary arrest and
unexpected death was created in the derivation sample (50% randomly selected from total cohort) using
multivariable logistic regression. The automated model was then validated in the remaining 50% from the total
cohort (validation sample). The primary outcome was a composite of resuscitation events, and death (RED). RED
included cardiopulmonary arrest, acute respiratory compromise and unexpected death. Predictors were measured
using data from the previous 24 hours. Candidate variables included vital signs, laboratory data, physician orders,
medications, floor assignment, and the Modified Early Warning Score (MEWS), among other treatment variables.
Results: RED rates were 1.2% of patient-days for the total cohort. Fourteen variables were independent predictors
of RED and included age, oxygenation, diastolic blood pressure, arterial blood gas and laboratory values, emergent
orders, and assignment to a high risk floor. The automated model had excellent discrimination (c-statistic=0.85) and
calibration and was more sensitive (51.6% and 42.2%) and specific (94.3% and 91.3%) than the MEWS alone. The
automated model predicted RED 15.9 hours before they occurred and earlier than Rapid Response Team (RRT)
activation (5.7 hours prior to an event, p=0.003)
Conclusion: An automated model harnessing EMR data offers great potential for identifying RED and was superior
to both a prior risk model and the human judgment-driven RRT.
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Out of intensive care unit (ICU) cardiac arrests and un-
expected deaths are common despite evidence that
patients often show signs of clinical deterioration hours
in advance [1-4]. This has prompted national organizations
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reproduction in any medium, provided the orteams (RRTs) as a strategy to prevent hospital deaths [5].
Such recommendations were made despite conflicting
evidence regarding the benefits of RRTs [3,6-10]. Some
have speculated that the indeterminate benefit of RRTs
is due to insufficiently predictive activation criteria and
poor response time by clinical staff [11]. Early warning
systems have been developed to identify deteriorating
patients using readily available clinical information
[12]. However, these early warning systems may not be
adequate because they 1) require monitoring and acti-
vation by often overburdened clinical staff, 2) fail to
systematically monitor all patients, and 3) demonstrateLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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risk of out of ICU cardiopulmonary arrest and death.
Early warning systems that are timely, accurate,
automated, and comprehensive in their surveillance are
needed.
The increasing use of electronic medical records
(EMR) in health care makes the use of computerized
prediction models possible. These models could repre-
sent powerful avenues to identify patients at high risk of
adverse events [13,14]. Though a few studies have
examined the accuracy of clinical automation to identify
patients at risk of clinical deterioration, they retain
limited utility since they do not fully harness the EMR,
produce no actionable alerts, define primary outcomes
differently, and do not allow for monitoring patients in
real time [15,16].
This study sought to 1) derive and validate an
automated prediction model based on near real-time
EMR data to identify patients at high risk of out of ICU
resuscitation events and death (RED), 2) compare the
test operating characteristics of the new automated
model to the previously published Modified Early
Warning Score (MEWS) [12] and human judgment-
activated institutional RRT, and 3) determine if the
automated model detected RED events sooner than the
human judgment activated RRT.
Methods
Setting and patient population
The automated prediction model was constructed using
data from adult patients admitted to Parkland Hospital,
a large urban academic hospital in Dallas, TX, between
May 18, 2009 and March 31, 2010. Patients were
included in the study if they were admitted to the in-
ternal medicine ward from either the emergency depart-
ment (ED) or outpatient clinics. Additionally, patients
were included if they were admitted to the ICU from the
ED. Patients were excluded if they were directly admit-
ted to the surgical floor or obstetrics or had a do not re-
suscitate (DNR) order at admission. However, any
hospital patient-days prior to a patient consenting to a
DNR order were included. To determine if early collec-
tion of data was predictive of events, all variables
included in the automated model were obtained from
the previous calendar day defined as time period be-
tween 12:00 AM and 11:59 PM. Therefore, events that
occurred on the first day of each hospitalization were
excluded. We also excluded any data within one hour of
an event to make sure the model did not include factors
that were early signs of resuscitation care. Patient-days
that occurred after an event were excluded. The research
protocol was approved by The University of Texas
Southwestern Institutional Review Board (IRB) which
concluded that the research presented no more thanminimal risk of harm to subjects. Therefore, the IRB
waived the need for informed consent.
Outcome variables
The primary outcome variable was defined as resuscitation
events or death (RED). Resuscitation events were defined
as out of ICU hospital codes and unplanned transfers to
the ICU. Hospital codes included cardiopulmonary
arrests (CPA) and acute respiratory compromise (ARC)
events, regardless of location, except those that occur
in the ICU for ICU length of stays >24 hours. CPA was
defined as an event in which chest compressions and/
or defibrillation are delivered, and an ARC event was
defined as an event requiring emergency assisted venti-
lation [17]. These events were identified electronically
through the hospital’s internal registry which is
structured on the American Heart Association’s Get
With The Guidelines – Resuscitation national registry, for-
mally known as the National Registry of Cardiopulmonary
Resuscitation [17]. This registry collects data on in-
hospital resuscitation events from hospitals across the
United States to provide feedback on an institution’s re-
suscitation practices and patient outcomes. Unplanned
ICU transfers included any transfers from the internal
medicine ward or ED to a medical or cardiac ICU requir-
ing an ICU length of stay >24 hours. We used unplanned
ICU transfer in the definition of a RED event because
these patients were in critical condition and would have a
high likelihood of CPA or death had the transfer not oc-
curred. There are no elective admissions to the ICU at this
institution. Unexpected death was defined as: 1) an in-
hospital death that occurred on the medical ward; or 2)
death that occurred in patients transferred to a medical or
cardiac ICU team with an ICU length of stay <24 hours.
Patient death and transfers to the medical or cardiac ICU
were identified electronically in the hospital’s EMR. The
date and time of bedside RRT activation was extracted
from the hospital’s systematic log of all RRT calls. Data
used to predict the primary outcome were extracted from
the previous calendar day.
Predictor variables
We developed a conceptual model of RED events based
on a comprehensive review of the literature and expert
clinical opinion. Candidate predictor variables for the
automated model were those extractable from the hos-
pital EMR (EPIC Systems Corporation, Verona, WI).
Data from the previous 24 hours calendar day were used
to determine the daily risk. Potential predictor variables
included the most abnormal laboratory value or vital
sign in the 24 hours period between 12:00 AM to
11:59 PM on each hospital day. We also examined other
possible indicators of impending RED events such as
STAT physician orders and medications. Medications of
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adverse events according to the Institute for Safe Medi-
cation Practices (ISMP). The MEWS is a previously
published risk score based on the number and degree of
vital sign and level of consciousness (LOC) abnormalities
(Additional file 1: Appendix A) [12]. We determined LOC
using a text-processing algorithm to read the free text in
nursing notes. Finally, we postulated that patients who
were more ill or unstable in subtle, hard-to-measure ways
could be preferentially admitted to certain non-ICU med-
ical floors, so we classified medicine wards accounting for
the top 15% of RED as “high risk floors.”
Derivation and validation of the automated prediction
model
The automated model was constructed in stages. First,
the total cohort was randomly split into derivation (50%)
and validation (50%) subsamples. We constructed the
final model using the derivation cohort. Second, recur-
sive partitioning was used to identify significant cut-
points in continuous candidate variables that were
associated with an increased rate of RED events. Third,
candidate predictors of RED events were identified using
univariate logistic regression. Continuous variables were
examined for nonlinear effects by testing the contributions
of spline functions and variable transformations. Fourth,
candidate variables significant at p ≤ 0.20 were entered
into a multivariate logistic regression model. Final model
variables were selected on the basis of conceptual and
statistical significance (p ≤0.05). The unit of analysis was
in patient-days.
The model based on the derivation dataset was
validated by comparing its performance in the validation
sample. Model discrimination was assessed with the c-
statistic and calibration with the Hosmer-Lemeshow
goodness-of-fit test [18]. Using cut-points determined by
the derivation subsample, five risk categories were
created on quintiles of predicted risk and graphically
assessed in the validation sample. To account for within
patient correlation, we used robust variance–covariance
matrix estimators for computing standard errors for
model coefficients.
Prior to model development, we assessed all variables
for missing values. For categorical and continuous
variables with less than 2% missing data, a missing cat-
egory was created, and the event rate was compared
with and pooled into the most appropriate reference
group. For categorical and continuous variables that had
greater than 2% missing data and were not measured
from one day to the next, a “never measured” category
was created and risk was compared to the other categories
or cut-points and pooled into the appropriate reference
group. Documentation by exception is a common ap-
proach in the predictive model literature [13,14,19,20].We determined relative contribution of each predictor
to RED events by examining the marginal increase in
the model chi-square accounted for by each predictor as
it was added and removed from the final automated
model [21,22].
Comparing performance of the automated model to the
MEWS
Patients were classified to be at risk of RED events at a
probability threshold of 4% as determined by the
automated model. Since the baseline risk for RED events
was assumed to be 1%, we considered a four times
greater than average risk an important threshold for con-
cern. Variables used to calculate the MEWS were obtained
in the previous calendar day between 12:00 AM to
11:59 PM. If a patient experienced a RED event, data from
the previous calendar day and those up to one hour prior
to the event were used to calculate the MEWS. A MEWS
of ≥5 was considered the critical threshold based on the
literature [12]. Sensitivity, specificity, positive predictive
value, and negative predictive value were determined for
both the automated model and the MEWS. The test
operating characteristics of the automated model and
the MEWS were compared using the c-statistic. Confi-
dence intervals were constructed for the c-statistics at
the 95% level [18].
Comparing performance of the automated model to the
institutional RRT
The institutional RRT is deployed when one or more of
the following is present in a patient: 1) heart rate <40 or
>130 beats/min, 2) systolic blood pressure <90 mmHg,
3) respiratory rate <8 or >30 breaths/min, 4) partial
pressure of oxygen <88% on room air, 5) oxygen require-
ment >50%, and 6) acute change in mental status. We
calculated the sensitivity, specificity, positive predictive
value and negative predictive value, along with 95% con-
fidence intervals, for both the automated model and the
institutional RRT. Moreover, we evaluated a subgroup of
patients that experienced an event who activated the in-
stitutional RRT and had a predicted probability of a RED
event of 4% by the automated model (model activation).
In this subgroup, we aimed to determine the difference
in time between model activation and RRT deployment.
We also evaluated the time difference between the
automated trigger of a RED event (patient’s predicted
probability of a RED event exceeds 4%) and RRT deploy-
ment, regardless of an event. Our hypothesis was that
the automated model would detect a patient who had a
RED event well in advance of the institutional RRT. We
compared this time difference using a paired Student’s
t-test. Analyses were conducted using STATA statistical
software (version 10.0; STATA Corp, College Station,
TX) and RTREE [23].
Table 1 Cohort characteristics (N=46,974 patient-days)
Derivation (n=23,127) Validation (n=23,847)
Number of Patients: 3624 3792
RED events a, n(%) 298 (1.3) 287 (1.2)
Demographics
Age, mean (SD) 50.5 (14.6) 51 (14.8)
Male, n(%) 2,062 (56.1) 2,049 (54)
Vital Signs, mean (SD)
Temperature (°F) 98.1 (1.6) 98.3 (1.8)
Systolic Blood Pressure (mm Hg) 139.8 (25.0) 139.6 (24.6)
Respirations per minute 21 (7.3) 20.7 (6.5)
Pulse per minute 91.3 (19.0) 92.1 (18.9)
Diastolic Blood Pressure (mm Hg) 83.8 (15.1) 83.9 (15.4)
SpO2 (%) 95.6 (5.1) 95.6 (5.0)
Laboratory Findings, mean (SD)
Platelets (103 cells/mm3) 242.3 (125.6) 237.8 (122.6)
Potassium (mEq/L) 4.0 (0.6) 4.0 (0.6)
Glucose (mg/dL) 128.6 (76.5) 127.8 (73.9)
Hematocrit (g/dL) 32.4 (6.8) 32.4 (6.7)
Creatinine (mg/dL) 2 (2.9) 1.8 (2.7)
White Blood Cell Count (103 cells/mm3) 8.6 (9.5) 8.6 (7.3)
Total Bilirubin (mg/dL) 1.5 (4.0) 1.5 (3.6)
Sodium (mEq/L) 135.8 (4.2) 135.8 (4.4)
Arterial pH 7.4 (0.1) 7.4 (0.1)
Arterial pCO2 (mm Hg) 37.5 (13.1) 38.9 (13.5)
AST (U/L) 95.6 (417.2) 74.5 (211.0)
Anion Gap 10.6 (3.9) 10.5 (4.0)
Albumin (g/dL) 3.2 (0.7) 3.2 (0.7)
B-type Natriuretic Peptide (pg/mL) 7,291.6 (14455.7) 6,357.2 (13019.8)
Thyroid Stimulating Hormone (μIU/mL) 5.4 (21.6) 4.4 (27.0)
Estimated Glomerular Filtration Rate (mL/min/1.73 m2) 50.5 (17.7) 50.7 (17.3)
Level of Consciousness 0.1 (0.4) 0.1 (0.3)
Provider Orders, n(%)
Bilevel positive airway pressure 122 (0.5) 178 (0.7)
Arterial Blood Gas 1,436 (6.2) 1,509 (6.3)
Troponin I 3,725 (16.1) 3,804 (16.0)
Electrocardiogram 4,996 (21.6) 5,143 (21.6)
Electroencephalogram 87 (0.4) 115 (0.5)
Telemetry 1,765 (7.6) 1,787 (7.5)
Stat order # 1 b 1,704 (7.4) 1,902 (8.0)
Stat order # 2 c 2,476 (10.7) 2,614 (11.0)
Administered Medications, n(%)
Institute of Safe Medication Practice High Alert Medication d 9,257 (40.0) 9,554 (40.1)
Systemic Steroids e 758 (3.3) 808 (3.4)
Sodium Bicarbonate 423 (1.8) 427 (1.8)
Lactulose or Rifaxamin 535 (2.3) 634 (2.7)
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Table 1 Cohort characteristics (N=46,974 patient-days) (Continued)
Antidote medication f 308 (1.3) 341 (1.4)
More than one nephrotoxic agent taken concurrently g 3,580 (15.5) 3,502 (14.7)
More than one antibiotic agent taken concurrently h 2,549 (11.0) 2,611 (11.0)
Intravenous fluid bolus 1,270 (5.5) 1,329 (5.6)
Stat acute coronary syndrome medications i 2,436 (10.5) 2,276 (9.5)
Stat seizure abatement medications j 1,069 (4.6) 1,234 (5.2)
Summary Variables
MEWS, mean (SD) k 2.2 (1.5) 2.2 (1.5)
High Risk Floor Assignment, n(%) l 2,369 (10.2) 2,348 (9.9)
a Resuscitation events and death; b Stat orders for head magnetic resonance imaging or computed tomography scan, chest plain film x-rays or computed
tomography scan, and abdominal ultrasonography; c Stat orders for complete blood count, bilevel positive airway pressure, arterial blood gas, troponin,
electroencephalogram and electrocardiogram; d antithrombotic agents, chemotherapeutic agents, epidural or intrathecal route of administration, hypoglycemic,
magnesium sulfate injection, hypertonic sodium chloride, colchicine injection, and methotrexate oral; e IV or oral prednisone, methylprednisolone, prednisolone,
fludricortisone and hydrocortisone; f Protamine, naloxone, phytonadione, flumazenil; g Systemic amphotericin B (lipid and conventional), systemic
aminoglycosides, scheduled daily non-steroidal anti-inflammatories, IV vancomycin, angiotensin converting enzyme inhibitors, angiotensin II receptor blockers,
cyclosporine, tacrolimus, loop diuretics, penicillin antibiotics, acyclovir; h Any aminoglycoside, penicillin, cephalosporin, vancomycin, sulfa antibiotic, linezolid,
doxycycline, tigecycline, fluoroquinolone, aztreonam, carbapenem, daptomycin, and nitrofurantoin; i IV metoprolol, sublingual or IV nitroglycerin and aspirin given
concurrently; j intramuscular lorazepam or diazepam, phenobarbital, fosphenytoin, and phenytoin; k elements consists of systolic blood pressure, heart rate,
respiratory rate, temperature, and level of consciousness; l includes floors that comprise the top 15% of events.
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Patient characteristics
A total of 7,466 hospitalized patients accounted for
46,974 patient-days. The derivation and validation
cohorts were evenly matched across demographic, clin-
ical, provider orders, administered medications and sum-
mary variables (Table 1). Mean age was 51.2 in the
derivation cohort and 51.4 in the validation cohort, and
56.1% and 54% were male, respectively.Primary outcomes and predictors of RED events
Major clinical deterioration occurred in 1 in 100
admissions (1.3% and 1.2% of hospitalizations in the der-
ivation and validation cohorts). The univariate predictors
of RED events are shown in Table 2 and included: older
age (>54 years), abnormal vital signs (temperature >99.5,
respiratory rate >24 bpm, DBP >125 mm/Hg), abnor-
mal laboratory values (e.g., potassium >5.1 mEq/L, glu-
cose >600 mg/dL, sodium <128 mEq/L), abnormal
arterial blood gas (ABG) results (pCO2 ≤22 mmHg or
pCO2 >70 mmHg), STAT physician orders (CBC order,
electrocardiogram order, ABG order), high risk floor as-
signment, high alert medication orders (ISMP high alert
medications, antidote medications, IV fluid bolus), level
of consciousness, and the MEWS score.
In the multivariable analysis, 14 variables were inde-
pendent predictors of RED events including: age >54 years,
abnormal vital signs (DBP >120 mmHg, SpO2 ≤86%)
abnormal laboratory values (AST >250 U/L, white
blood cell count >11 × 103 cells/mm3, platelets <100 × 103
cells/mm3, potassium >5.1 mEq/L), abnormal ABG results
(pCO2 ≤22 mmHg or pCO2 >70 mmHg), physicianorders for an ABG, electrocardiogram, STAT orders for
head computed tomography (CT) or magnetic resonance
imaging, chest CT, abdominal ultrasound, and chest
x-rays, high risk floor assignment and summary MEWS
score (Table 3). The strongest individual indicators of
RED events were: abnormal ABG results and high risk
floor assignment.Performance of the automated model
The final automated model had good discrimination in
both the derivation and validation dataset with a c-statistic
of 0.87 (95% CI 0.85-0.89) and 0.85 (95% CI 0.82 - 0.87),
and was well-calibrated (Hosmer Lemeshow test p=0.12).
It also stratified patients across a wide spectrum of risk
from 0.14% in the lowest quintile to 4.3% in the highest
one (Figure 1). The principal influencing variables in the
automated model as assessed by the uniquely attributable
chi-square were high risk floor assignment (37.9%)
followed by the MEWS (25.5%), demographics, laboratory
and vital signs (18.2%), and physician orders (18.4%).Comparing the performance of the automated model
performance and the MEWS
The automated model was both more sensitive (51.6%
and 42.2%) and specific (94.3% and 91.3%) than the
MEWS. The positive predictive value (PPV) of the
automated model was superior to the MEWS (10% and
5.6%). The negative predictive values (NPV) were simi-
lar (99.4% and 99.2%). The automated model performed
significantly better than the MEWS with a c-statistic of
0.85 (95% CI 0.82 - 0.87) compared to a c-statistic of
0.75 (95% CI 0.71 - 0.78) (Figure 2).
Table 2 Univariate predictors of RED events (N= 23,127 patient days)
Variable Derivation Events # (%) Odds Ratio (95% CI) p
RED events a 298 (1.3)
age > 54 9,217 (39.9) 145 (1.6) 1.4 (1.14 - 1.81) 0.002
Vitals, N(%)
Temperature (°F)
≤99.5 (ref.) 20,157 (87.2) 229 (1.1) – –
>99.5 2,970 (12.8) 69 (2.3) 2.1 (1.58 - 2.72) <0.001
Systolic Blood Pressure (mm Hg)
≤125 (ref.) 7,122 (30.8) 77 (1.1) – –
>125 16,005 (69.2) 221 (1.4) 1.3 (0.99 - 1.66) 0.063
Respirations per minute
≤24 (ref.) 21,713 (93.9) 192 (0.9) – –
>24 1,414 (6.1) 106 (7.5) 9.1 (7.12 - 11.59) <0.001
Pulse per minute
≤134 (ref.) 22,464 (97.1) 240 (1.1) – –
>134 663 (2.9) 58 (8.8) 8.9 (6.59 - 11.96) <0.001
Diastolic Blood Pressure (mm Hg)
≤120 (ref.) 22,507 (97.3) 265 (1.2) – –
>120 620 (2.7) 33 (5.3) 4.7 (3.26 - 6.84) <0.001
spO2 (%)
≤86 319 (1.4) 25 (7.8) 7.0 (4.59 - 10.74) <0.001
>86 (ref.) 22,808 (98.6) 273 (1.2) – –
Laboratory, N(%)
Platelets (103 cells/mm3)
<100 1959 (8.5) 32 (1.6) 1.3 (0.90 - 1.89) 0.158
≥100 (ref.) 21,168 (91.5) 266 (1.3) – –
Potassium (mEq/L)
≤2.9 155 (0.7) 9 (5.8) 5.4 (2.74 - 10.76) <0.001
2.9 - 5.1 (ref.) 21,811 (94.3) 245 (1.1) – –
>5.1 1,161 (5.0) 44 (3.8) 3.5 (2.50 - 4.81) <0.001
Glucose (mg/dL)
≤250 (ref.) 22,219 (96.0) 276 (1.2) – –
250 – 600 825 (3.6) 17 (2.1) 1.7 (1.02 - 2.74) 0.042
>600 83 (0.4) 5 (6.0) 5.1 (2.05 - 12.69) <0.001
Hematocrit (g/dL)
≤48 (ref.) 22,925 (99.1) 288 (1.3) – –
> 48 202 (0.9) 10 (5.0) 4.1 (2.15 - 7.81) <0.001
Creatinine
≤1.5 (ref.) 17,937 (77.6) 201 (1.1) – –
>1.5 5,190 (22.4) 97 (1.9) 1.7 (1.32 - 2.15) <0.001
White Blood Cell Count (103 cells/mm3)
≤11 (ref.) 19,225 (83.1) 204 (1.1) – –
>11 3,902 (16.9) 94 (2.4) 2.3 (1.80 - 2.95) <0.001
Total Bilirubin (mg/dL)
≤1.7 (ref.) 22,172 (95.9) 271 (1.2) – –
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Table 2 Univariate predictors of RED events (N= 23,127 patient days) (Continued)
>1.7 955 (4.1) 27 (2.8) 2.4 (1.57 - 3.51) <0.001
Sodium (mEq/L)
≤128 983 (4.2) 29 (3.0) 2.5 (1.69 - 3.69) <0.001
128 - 143 (ref.) 21,808 (94.3) 262 (1.2) – –
>143 336 (1.5) 7 (2.1) 1.7 (0.82 - 3.74) 0.148
pH
≤7.22 53 (0.2) 11 (20.8) 20.8 (10.60 - 40.80) <0.001
>7.22 (ref.) 23,074 (99.8) 287 (1.2) – –
pCO2 (mm Hg)
≤22 78 (0.3) 12 (15.4) 14.8 (7.89 - 27.62) <0.001
22 - 70 (ref.) 23,020 (99.5) 280 (1.2) – –
>70 29 (0.2) 6 (20.7) 21.2 (8.56 - 52.43) <0.001
AST (U/L)
≤250 (ref.) 22,826 (98.7) 279 (1.2) – –
>250 301 (1.3) 19 (6.3) 5.4 (3.37 - 8.79) <0.001
Anion Gap
≤16 (ref.) 21,791 (94.2) 236 (1.1) – –
>16 1,336 (5.8) 62 (4.6) 4.4 (3.34 - 5.91) <0.001
Albumin (g/dL)
< 3.5 2,779 (12.0) 54 (1.9) 1.6 (1.21 - 2.20) 0.001
≥3.5 (ref.) 20,348 (88.0) 244 (1.2) – –
B-type natriuretic peptide (pg/mL)
≤100 (ref.) 21,803 (94.3) 257 (1.2) – –
>100 1,324 (5.7) 41 (3.1) 2.7 (1.92 - 3.74) <0.001
Thyroid Stimulating Hormone (μIU/mL)
≤0.4 60 (0.3) 3 (5.0) 4.1 (1.27 - 13.10) 0.018
0.4 - 5.4 610 (2.6) 7 (1.2) 0.9 (0.42 - 1.91) 0.784
>5.4 83 (0.4) 3 (3.6) 2.9 (0.91 - 9.26) 0.071
Not measured (ref.) 22,374 (96.7) 285 (1.3) – –
Estimated glomerular filtration rate (mL/min/1.73 m2)
≤30 3,009 (13.0) 57 (1.9) 1.6 (1.19 - 2.13) 0.002
>30 (ref.) 20,118 (87.0) 241 (1.2) – –
Physician Orders, N(%)
Bilevel positive airway pressure 122 (0.5) 11 (9.0) 7.8 (4.18 - 14.73) <0.001
Arterial Blood Gas 1,436 (6.2) 104 (7.2) 8.7 (6.77 - 11.05) <0.001
Troponin I 3,725 (16.1) 130 (3.5) 4.1 (3.28 - 5.22) <0.001
Electrocardiogram 4,996 (21.6) 183 (3.7) 6.0 (4.71 - 7.54) <0.001
Electroencephalogram 87 (0.4) 1 (1.2) 0.9 (0.12 - 6.41) 0.908
Telemetry 1,765 (7.6) 36 (2.0) 1.7 (1.18 - 2.38) 0.004
Stat order # 1 b 1,704 (7.4) 45 (2.6) 2.3 (1.65 - 3.13) <0.001
Stat order # 2 c 2,476 (10.7) 70 (2.8) 2.6 (1.99 - 3.42) <0.001
Administered Medications, N(%)
Institute of Safe Medication Practice High Alert Medication d 9,257 (40.0) 162 (1.8) 1.8 (1.43 - 2.26) <0.001
Systemic Steroids e 758 (3.3) 13 (1.7) 1.4 (0.77 - 2.37) 0.292
Sodium Bicarbonate 423 (1.8) 16 (3.8) 3.1 (1.87 - 5.22) <0.001
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Table 2 Univariate predictors of RED events (N= 23,127 patient days) (Continued)
Lactulose or Rifaxamin 535 (2.3) 12 (2.2) 1.8 (1.00 - 3.21) 0.051
Antidote medication f 308 (1.3) 14 (4.6) 3.8 (2.18 - 6.54) <0.001
More than one nephrotoxic agent taken concurrently g 3,580 (15.5) 60 (1.7) 1.4 (1.04 - 1.84) 0.026
More than one antibiotic agent taken concurrently h 2,549 (45.3) 46 (1.8) 1.5 (1.08 - 2.04) 0.015
Intravenous fluid bolus 1,270 (5.5) 55 (4.3) 4.0 (2.99 - 5.43) <0.001
Stat acute coronary syndrome medications i 2,436 (10.5) 43 (1.8) 1.4 (1.04 - 1.99) 0.028
Stat seizure abatement medications j 1,069 (4.6) 31 (2.9) 2.4 (1.67 - 3.55) <0.001
Summary Variables
MEWS, Mean (SD) k 2.28 (1.5) 1.6 (1.54 - 1.70) <0.001
Level of Consciousness
0 – Alert 7,580 (32.8) 156 (2.1) 3.1 (2.41 - 4.00) <0.001
1 – Responds to voice/new confusion/restlessness 543 (2.3) 23 (4.2) 6.5 (4.12 - 10.37) <0.001
2 – Responds to pain 102 (0.4) 6 (5.9) 9.2 (3.95 - 21.55) <0.001
3 – Unresponsive 32 (0.1) 13 (40.6) 101.1 (48.59 - 210.20) <0.001
Not measured (ref.) 14,870 (64.3) 100 (0.7) – –
High Risk Floor Assignment, N(%) l 2,369 (10.2) 158 (6.7) 10.5 (8.35 - 13.27) <0.001
a Resuscitation events and death; b Stat orders for head magnetic resonance imaging or computed tomography scan, chest plain film x-rays or computed
tomography scan, and abdominal ultrasonography; c Stat orders for complete blood count, bilevel positive airway pressure, arterial blood gas, troponin,
electroencephalogram and electrocardiogram; d antithrombotic agents, chemotherapeutic agents, epidural or intrathecal route of administration, hypoglycemic,
magnesium sulfate injection, hypertonic sodium chloride, colchicine injection, and methotrexate oral; e IV or oral prednisone, methylprednisolone, prednisolone,
fludricortisone and hydrocortisone; f Protamine, naloxone, phytonadione, flumazenil; g Systemic amphotericin B (lipid and conventional), systemic
aminoglycosides, scheduled daily non-steroidal anti-inflammatories, IV vancomycin, angiotensin converting enzyme inhibitors, angiotensin II receptor blockers,
cyclosporine, tacrolimus, loop diuretics, penicillin antibiotics, acyclovir; h Any aminoglycoside, penicillin, cephalosporin, vancomycin, sulfa antibiotic, linezolid,
doxycycline, tigecycline, fluoroquinolone, aztreonam, carbapenem, daptomycin, and nitrofurantoin; i IV metoprolol, sublingual or IV nitroglycerin and aspirin given
concurrently; j intramuscular lorazepam or diazepam, phenobarbital, fosphenytoin, and phenytoin; k elements consists of systolic blood pressure, heart rate,
respiratory rate, temperature, and level of consciousness; l includes floors that comprise the top 15% of events.
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the RRT calls
The RRT was activated for 357 of eligible study patients
as part of usual care during the study period. The
automated model was more sensitive than the RRT
(51.6% vs. 25.8%). However, it was slightly less specific
than the RRT (98.8% vs. 94.3%). The RRT had a better
PPV than the automated model (21% and 10%) and
similar NPV (99.1% and 99.4%). The median number of
times the automated model flagged patients at risk per
day during the study period was 9 and the median num-
ber of RRT calls per day was 2.
There were a total of 17 patients who were at risk of
RED events by the automated model, where the institu-
tional RRT was deployed and experienced a RED event.
The automated model predicted an event 15.9 (±7.7)
hours before the actual event occurred compared to the
RRT which was called a mean of 8.4 (±8.5) hours prior
the actual event (p=0.003). Overall, the automated model
also determined a patient to be at risk 5.7 hours (95% CI
3.1-8.3) earlier than the RRT was called for all types of
RED events.
Discussion
We developed and validated a novel, automated model
using the EMR for predicting RED events in patientsadmitted to the hospital. From a statistical perspective,
the automated model had excellent discrimination, was
well-calibrated, and had outstanding specificity (94.3%)
and good sensitivity (51.6%). The automated model also
had better discrimination, sensitivity and specificity than
the previously published MEWS. From a practical stand-
point, the model identified patients destined to have
RED event on average 16 hours (or more than one nurs-
ing shift) before they actually experienced a major clin-
ical event. Further, the automated model was able to
accurately predict RED events using information
obtained from the previous 24 hours. Together with its
ability to screen all patients systematically and automat-
ically, low false positive rate, and advance notice, the
automated model appears to provide both accurate and
actionable intelligence.
Since the growing standard of care is to use the RRTs
to meet this goal, we were particularly interested in the
more practical comparison of the new model to the
human or manually activated RRT approach used in our
hospital. Overall, the automated model had twice the
sensitivity of the RRT (51.6% v. 25.8%), demonstrating
that computerized surveillance is likely to identify more
patients at risk for major adverse events compared to
providers’ clinical judgment. The automated model
achieved this much higher sensitivity with only a small
Table 3 Multivariate predictors of RED events (derivation cohort, N= 23,127)
Variables Odds Ratio (95% CI) P Value
Demographics/Laboratory/Vital Signs
Age >54 years 1.59 (1.24 - 2.04) <0.001
SpO2 (%) (min) ≤86 1.73 (1.04 - 2.88) 0.03
Diastolic BP (mm Hg) (max) >120 3.17 (1.16 - 8.66) 0.03
AST (U/L) (min) >250 2.89 (1.62 - 5.17) <0.001
pCO2 (mm Hg) (max) ≤22 3.72 (1.64 - 8.40) 0.002
pCO2 (mm Hg) (max) >70 4.61 (1.84 - 11.56) 0.001
WBC (103 cells/mm3) (min) >11 1.36 (1.03 - 1.79) 0.03
Platelets (103 cells/mm3) (min) <100 1.76 (1.18 - 2.64) 0.01
Potassium (mEq/dL) (max) >5.1 1.77 (1.22 - 2.56) 0.003
Orders
Arterial Blood Gas 2.08 (1.52 - 2.85) <0.001
Electrocardiogram 2.05 (1.54 - 2.73) <0.001
Stat Physician Order a 2.20 (1.53 - 3.16) <0.001
Summary Variable
High Risk Floor Assignment b 5.71 (4.34 - 7.51) <0.001
MEWS c 1.36 (1.28 - 1.44) <0.001
Derivation: 0.87 (0.85 - 0.89) - 298 events
Validation: 0.85 (0.82 - 0.87) - 287 events
a Stat orders for head magnetic resonance imaging or computed tomography scan, chest plain film x-rays or computed tomography scan, and abdominal ultrasonography;
b includes floors that comprise the top 15% of events; c elements consists of systolic blood pressure, heart rate, respiratory rate, temperature, and level of consciousness.
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greatest importance from a patient safety viewpoint, the
automated model flagged patients 5.7 hours sooner than
the RRT. Accurately identifying patients earlier in of the
course of physiological deterioration should be expected
to yield greater opportunity for rescue.Figure 1 Observed rates of RED events stratified by quintiles of risk i
and group 5 is the highest quintile of risk. The Figure shows comparable perforThe superior performance of the new model likely
came from the richer source of information available in
the EMR which is unavailable to simpler vital sign based
models. In addition, monitoring physician orders for ECG,
ABG or other STAT orders appears to be an important pre-
dictive measure, perhaps reflecting a physician’s escalatingn the automated model. Legend: Group 1 is the lowest quintile of risk
mance in the derivation (white bars) and validation (black bars) samples.
Figure 2 Comparing Receiver Operator Characteristic curve
performance for final automated model versus the MEWS.
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high risk floor assignment, may be a proxy for nurse
staffing ratios, physician team composition, or other un-
known system or process-related factors that are associated
with increased acuity or risk.
We were somewhat surprised that none of the medica-
tion variables were included in the final model, despite
looking at many candidate predictors. This result may
be due to the administration of antidote medicines that
occur late in the process of clinical deterioration. The
risk of causing RED events due to use of high risk
medicines may be mediated through their effect on vital
sign and laboratory abnormalities and partly depend on
a patient’s underlying hepatic and renal physiological re-
serve. There is a need to explore more complex drug
interactions and their association with adverse events.
The 1.3% prevalence in this study is similar to that
seen in other studies [3,6]. The performance of the
MEWS in this study was also consistent with prior
reports (c-statistic=0.75), confirming its moderate pre-
dictive capabilities [12,15]. Our institution had an RRT
call rate similar to those observed elsewhere [24].
Several limitations are worth noting. First, we used
retrospective data from a single urban health system to
derive and validate our model. While the rate of RED
events and RRT calls in this sample is similar to other
studies, the generalizability of this model to other pa-
tient populations and health systems is unknown and
merits further investigation [3]. Second, the derivation
and validation of the novel model was done retrospect-
ively, so the next step would be prospective validation
ideally in more than one setting. Third, and even moreimportantly, the ultimate value of the automated model
will depend on whether it can realistically be used in
real-time and if flagging patients at high risk will change
clinical management, improves patient outcomes and/or
reduces human surveillance burden. While we hypothesize
that earlier warning and proper identification of patients at
risk will decrease RED events, this has yet to be shown.
Fourth, although the automated model achieves a
c-statistic of 0.85, there is a moderate false positive rate.
However, given the severity of RED events, we accept the
false positive rate in exchange for greater model sensitivity.
More work is necessary to prevent the activation of
overburdened clinical staff to false alerts. Fifth, there may
be some difficulty generalizing “high risk floors”, although,
institutions can determine the rate of RED for each floor
and establish which areas comprise the top 15% of events.
Finally, our model uses data derived from a comprehensive
EMR, so it may only be useful in such settings. However,
the deployment of integrated EMRs in hospitals has been
accelerating greatly due to recent federal investments in
health information technology and is expected to continue
over the next 5 to 10 years [25-27]. While our model has
robust predictive capabilities, we believe employing add-
itional technologies such as natural language processing
may further improve prediction. Another area of promise
involves more sophisticated adverse drug event detection
software to further classify risk and improve prediction of
poor hospital outcomes.
Conclusion
One in 100 hospitalized medical patients experienced RED
events, among the most serious of all adverse patient safety
outcomes. The novel, EMR-based model we developed
was better at predicting these serious adverse events
compared to prior risk models and the human judgment
based RRT approach. While formal prospective implemen-
tation and evaluation of such a computerized RED event
risk detection strategy is needed in the form of a controlled
trial, this automated prediction model could be a powerful
tool in the effort to reduce out of ICU CPA, unplanned
transfers to the ICU, and death. Models such as ours may
foreshadow higher level “meaningful use” of EMRs to im-
prove inpatient outcomes.
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